|
|
|
|
|
||
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 108, Issue 12 3695-3702, Copyright © 1995 by Company of Biologists
JOURNAL ARTICLES |
D Ohmer-Schrock, C Schlatterer, H Plattner and J Schlepper-Schafer
University Konstanz, Faculty of Biology, Germany.
Lung surfactant protein A (SP-A), the main protein component of lung surfactant which lines the alveoli, strongly enhances serum-independent phagocytosis of bacteria by rat alveolar macrophages. We tested if the effect of SP-A is due to interaction with the macrophages or to opsonization of the bacteria. In phagocytosis assays with fluorescein isothiocyanate labeled bacteria, SP-A had no opsonic effect on Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus, but enhanced phagocytosis by acting only on the macrophages. We characterized this activation mechanism. With single cell measurements of fura-2 loaded cells we demonstrate that SP-A raises the intracellular free calcium ion concentration 6 to 8 seconds after addition. This calcium mobilization is dose-dependent in that increased SP-A concentrations lead to a higher percentage of responding cells. Additionally, SP-A leads to a dose-dependent and transient generation of inositol 1,4.5-trisphosphate. Release of intracellular stored calcium by SP-A is a prerequisite for its stimulatory effect on phagocytosis, since SP-A-induced enhancement of phagocytosis can be impaired by prior addition of thapsigargin, a Ca(2+)-ATPase inhibitor that leads to depletion of intracellular calcium stores. We conclude that SP-A activates a phosphoinositide/calcium signaling pathway in alveolar macrophages leading to enhanced serum-independent phagocytosis of bacteria.
This article has been cited by other articles:
|
|
 |
|
  A. N. Mikerov, T. M. Umstead, X. Gan, W. Huang, X. Guo, G. Wang, D. S. Phelps, and J. Floros Impact of ozone exposure on the phagocytic activity of human surfactant protein A (SP-A) and SP-A variants Am J Physiol Lung Cell Mol Physiol, January 1, 2008; 294(1): L121 - L130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Giannoni, T. Sawa, L. Allen, J. Wiener-Kronish, and S. Hawgood Surfactant Proteins A and D Enhance Pulmonary Clearance of Pseudomonas aeruginosa Am. J. Respir. Cell Mol. Biol., June 1, 2006; 34(6): 704 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Beharka, J. E. Crowther, F. X. McCormack, G. M. Denning, J. Lees, E. Tibesar, and L. S. Schlesinger Pulmonary Surfactant Protein A Activates a Phosphatidylinositol 3-Kinase/Calcium Signal Transduction Pathway in Human Macrophages: Participation in the Up-Regulation of Mannose Receptor Activity J. Immunol., August 15, 2005; 175(4): 2227 - 2236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Mikerov, T. M. Umstead, W. Huang, W. Liu, D. S. Phelps, and J. Floros SP-A1 and SP-A2 variants differentially enhance association of Pseudomonas aeruginosa with rat alveolar macrophages Am J Physiol Lung Cell Mol Physiol, January 1, 2005; 288(1): L150 - L158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Alcorn and J. R. Wright Surfactant protein A inhibits alveolar macrophage cytokine production by CD14-independent pathway Am J Physiol Lung Cell Mol Physiol, January 1, 2004; 286(1): L129 - L136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Korfhagen Surfactant Protein A (SP-A)-Mediated Bacterial Clearance . SP-A and Cystic Fibrosis Am. J. Respir. Cell Mol. Biol., December 1, 2001; 25(6): 668 - 672. [Full Text] [PDF]
|
|
|
|
|
|
K. R. Khubchandani, R. E. Oberley, and J. M. Snyder Effects of Surfactant Protein A and NaCl Concentration on the Uptake of Pseudomonas aeruginosa by THP-1 Cells Am. J. Respir. Cell Mol. Biol., December 1, 2001; 25(6): 699 - 706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Hickman-Davis, F. C. Fang, C. Nathan, V. L. Shepherd, D. R. Voelker, and J. R. Wright Lung surfactant and reactive oxygen-nitrogen species: antimicrobial activity and host-pathogen interactions Am J Physiol Lung Cell Mol Physiol, September 1, 2001; 281(3): L517 - L523. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yang, C. Milla, A. Panoskaltsis-Mortari, D. H. Ingbar, B. R. Blazar, and I. Y. Haddad Human Surfactant Protein A Suppresses T Cell-Dependent Inflammation and Attenuates the Manifestations of Idiopathic Pneumonia Syndrome in Mice Am. J. Respir. Cell Mol. Biol., May 1, 2001; 24(5): 527 - 536. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. R. KHUBCHANDANI and J. M. SNYDER Surfactant protein A (SP-A): the alveolus and beyond FASEB J, January 1, 2001; 15(1): 59 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. I. Mariencheck, J. Savov, Q. Dong, M. J. Tino, and J. R. Wright Surfactant protein A enhances alveolar macrophage phagocytosis of a live, mucoid strain of P. aeruginosa Am J Physiol Lung Cell Mol Physiol, October 1, 1999; 277(4): L777 - L786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Schagat, M. J. Tino, and J. R. Wright Regulation of Protein Phosphorylation and Pathogen Phagocytosis by Surfactant Protein A Infect. Immun., September 1, 1999; 67(9): 4693 - 4699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. LeVine, K. E. Kurak, M. D. Bruno, J. M. Stark, J. A. Whitsett, and T. R. Korfhagen Surfactant Protein-A-Deficient Mice Are Susceptible to Pseudomonas aeruginosa Infection Am. J. Respir. Cell Mol. Biol., October 1, 1998; 19(4): 700 - 708. [Abstract] [Full Text]
|
|
|
|
|
|
E. C. Crouch Collectins and Pulmonary Host Defense Am. J. Respir. Cell Mol. Biol., August 1, 1998; 19(2): 177 - 201. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Keisari, K. Kabha, L. Nissimov, J. Schlepper-Schafer, and I. Ofek Phagocyte-Bacteria Interactions Advances in Dental Research, April 1, 1997; 11(1): 43 - 49. [Abstract] [PDF]
|
|
|
|
|
|
J. M. Hickman-Davis, P. O'Reilly, I. C. Davis, J. Peti-Peterdi, G. Davis, K. R. Young, R. B. Devlin, and S. Matalon Killing of Klebsiella pneumoniae by human alveolar macrophages Am J Physiol Lung Cell Mol Physiol, May 1, 2002; 282(5): L944 - L956. [Abstract] [Full Text] [PDF]
|
|
